Wellington Management Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-75,161
| Closed | -$247K | – | 1928 |
|
2024
Q2 | $247K | Buy |
75,161
+30,976
| +70% | +$102K | ﹤0.01% | 1837 |
|
2024
Q1 | $324K | Buy |
+44,185
| New | +$324K | ﹤0.01% | 1834 |
|
2022
Q4 | – | Sell |
-568,382
| Closed | -$12.7M | – | 2031 |
|
2022
Q3 | $12.7M | Sell |
568,382
-22,297
| -4% | -$500K | ﹤0.01% | 1035 |
|
2022
Q2 | $14.6M | Sell |
590,679
-140,446
| -19% | -$3.48M | ﹤0.01% | 1027 |
|
2022
Q1 | $28.3M | Buy |
731,125
+31,373
| +4% | +$1.22M | ﹤0.01% | 936 |
|
2021
Q4 | $40.9M | Buy |
699,752
+89,212
| +15% | +$5.22M | 0.01% | 891 |
|
2021
Q3 | $36.2M | Buy |
610,540
+359,535
| +143% | +$21.3M | 0.01% | 918 |
|
2021
Q2 | $21.8M | Buy |
251,005
+70,557
| +39% | +$6.12M | ﹤0.01% | 1076 |
|
2021
Q1 | $14.9M | Sell |
180,448
-13,797
| -7% | -$1.14M | ﹤0.01% | 1139 |
|
2020
Q4 | $17.7M | Buy |
+194,245
| New | +$17.7M | ﹤0.01% | 1066 |
|
2020
Q1 | – | Sell |
-39,006
| Closed | -$764K | – | 1957 |
|
2019
Q4 | $764K | Buy |
+39,006
| New | +$764K | ﹤0.01% | 1771 |
|
2016
Q1 | – | Sell |
-1,306,569
| Closed | -$4.4M | – | 2135 |
|
2015
Q4 | $4.4M | Sell |
1,306,569
-155,953
| -11% | -$526K | ﹤0.01% | 1398 |
|
2015
Q3 | $7.8M | Sell |
1,462,522
-37,126
| -2% | -$198K | ﹤0.01% | 1241 |
|
2015
Q2 | $9.7M | Buy |
1,499,648
+41,950
| +3% | +$271K | ﹤0.01% | 1231 |
|
2015
Q1 | $7.13M | Buy |
1,457,698
+36,770
| +3% | +$180K | ﹤0.01% | 1344 |
|
2014
Q4 | $7.15M | Buy |
1,420,928
+1,953
| +0.1% | +$9.82K | ﹤0.01% | 1334 |
|
2014
Q3 | $7.29M | Buy |
1,418,975
+224,965
| +19% | +$1.16M | ﹤0.01% | 1331 |
|
2014
Q2 | $7.53M | Buy |
1,194,010
+72,830
| +6% | +$459K | ﹤0.01% | 1332 |
|
2014
Q1 | $10.9M | Sell |
1,121,180
-76,020
| -6% | -$740K | ﹤0.01% | 1215 |
|
2013
Q4 | $7.52M | Buy |
+1,197,200
| New | +$7.52M | ﹤0.01% | 1338 |
|